AbbVie Inc.
GB ˙ LSE ˙ US00287Y1091
229,00 $ ↑6,18 (2,77%)
2026-06-05
DEL PRIS
SecurityGB:0QCV / AbbVie Inc.
InstitutionCullinan Associates Inc
Latest Disclosed Ownership73,455 shares
Latest Disclosed Value $ 15,975,728
Cullinan Associates Inc reports 11.90% decrease in ownership of 0QCV / AbbVie Inc.

On May 1, 2026 - Cullinan Associates Inc filed a 13F-HR form disclosing ownership of 73,455 shares of AbbVie Inc. (GB:0QCV) valued at $15,904,477 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 83,375 shares of AbbVie Inc.. This represents a change in shares of -11.90% during the quarter. The current value of the position is $16,821,195 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F AbbVie COM 00287Y109 73,455 -9,920 -11.90 15,976 -16.14 1.2921
2026-01-30 2025-12-31 13F AbbVie COM 00287Y109 83,375 -1,411 -1.66 19,050 -2.96 1.2912
2025-10-27 2025-09-30 13F AbbVie COM 00287Y109 84,786 -3,357 -3.81 19,631 19.99 1.2782
2025-07-22 2025-06-30 13F AbbVie COM 00287Y109 88,143 -3,573 -3.90 16,361 -14.86 1.0791
2025-04-22 2025-03-31 13F AbbVie COM 00287Y109 91,716 -2,061 -2.20 19,216 15.31 1.3585
2025-01-24 2024-12-31 13F AbbVie COM 00287Y109 93,777 -15,625 -14.28 16,664 -18.41 1.0696
2024-10-23 2024-09-30 13F AbbVie COM 00287Y109 109,402 -11,206 -9.29 20,424 -1.27 1.1519
2024-07-10 2024-06-30 13F AbbVie COM 00287Y109 120,608 -6,508 -5.12 20,687 -10.63 1.1705
2024-04-18 2024-03-31 13F AbbVie COM 00287Y109 127,116 -3,295 -2.53 23,148 14.54 1.2981
2024-01-24 2023-12-31 13F AbbVie COM 00287Y109 130,411 -20,680 -13.69 20,210 -10.27 1.1268
2023-10-11 2023-09-30 13F AbbVie COM 00287Y109 151,091 13,226 9.59 22,522 21.25 1.3117
2023-07-14 2023-06-30 13F AbbVie COM 00287Y109 137,865 5,261 3.97 18,575 -12.11 1.0210
2023-04-05 2023-03-31 13F AbbVie COM 00287Y109 132,604 7,080 5.64 21,133 105,565.00 1.2346
2023-01-11 2022-12-31 13F AbbVie COM 00287Y109 125,524 3,947 3.25 20 -99.88 1.1241
2022-10-19 2022-09-30 13F AbbVie COM 00287Y109 121,577 -3,714 -2.96 16,317 -14.97 1.0304
2022-07-08 2022-06-30 13F AbbVie COM 00287Y109 125,291 8,145 6.95 19,190 1.05 1.1732
2022-04-21 2022-03-31 13F AbbVie COM 00287Y109 117,146 -10,297 -8.08 18,991 10.05 0.9965
2022-01-07 2021-12-31 13F AbbVie COM 00287Y109 127,443 36,841 40.66 17,256 76.57 0.8784
2021-10-08 2021-09-30 13F AbbVie COM 00287Y109 90,602 12,353 15.79 9,773 10.88 0.5399
2021-07-07 2021-06-30 13F AbbVie COM 00287Y109 78,249 23,757 43.60 8,814 49.47 0.4936
2021-04-20 2021-03-31 13F AbbVie COM 00287Y109 54,492 40,661 293.98 5,897 297.91 0.3393
2021-01-14 2020-12-31 13F AbbVie COM 00287Y109 13,831 6,700 93.96 1,482 137.12 0.0889
2020-10-09 2020-09-30 13F AbbVie COM 00287Y109 7,131 -1,800 -20.15 625 -28.73 0.0403
2020-07-07 2020-06-30 13F AbbVie COM 00287Y109 8,931 2,031 29.43 877 66.73 0.0615
2020-04-01 2020-03-31 13F AbbVie COM 00287Y109 6,900 -4,800 -41.03 526 -49.23 0.0430
2020-01-15 2019-12-31 13F AbbVie COM 00287Y109 11,700 -400 -3.31 1,036 13.10 0.0693
2019-10-01 2019-09-30 13F AbbVie COM 00287Y109 12,100 1,900 18.63 916 23.45 0.0652
2019-07-16 2019-06-30 13F AbbVie COM 00287Y109 10,200 -1,300 -11.30 742 -19.96 0.0539
2019-04-30 2019-03-31 13F AbbVie COM 00287Y109 11,500 3,330 40.76 927 23.11 0.0696
2019-01-11 2018-12-31 13F AbbVie COM 00287Y109 8,170 0 0.00 753 -2.59 0.0622
2018-10-19 2018-09-30 13F AbbVie COM 00287Y109 8,170 -1,600 -16.38 773 -14.59 0.0560
2018-07-09 2018-06-30 13F AbbVie COM 00287Y109 9,770 300 3.17 905 1.00 0.0692
2018-04-26 2018-03-31 13F AbbVie COM 00287Y109 9,470 2,500 35.87 896 32.94 0.0679
2018-01-17 2017-12-31 13F AbbVie COM 00287Y109 6,970 -14,700 -67.84 674 -65.01 0.0495
2017-10-16 2017-09-30 13F AbbVie COM 00287Y109 21,670 -2,000 -8.45 1,926 12.24 0.1483
2017-07-12 2017-06-30 13F AbbVie COM 00287Y109 23,670 200 0.85 1,716 12.23 0.1336
2017-04-17 2017-03-31 13F AbbVie COM 00287Y109 23,470 330 1.43 1,529 5.52 0.1247
2017-01-30 2016-12-31 13F AbbVie COM 00287Y109 23,140 -90,560 -79.65 1,449 -79.79 0.1234
2016-10-03 2016-09-30 13F AbbVie COM 00287Y109 113,700 1,200 1.07 7,171 2.96 0.6130
2016-07-01 2016-06-30 13F AbbVie COM 00287Y109 112,500 13,750 13.92 6,965 23.47 0.5662
2016-05-20 2016-03-31 13F AbbVie COM 00287Y109 98,750 12,400 14.36 5,641 10.28 0.4818
2016-01-12 2015-12-31 13F Abbvie COM 00287Y109 86,350 -13,830 -13.81 5,115 -6.16 0.4453
2015-10-05 2015-09-30 13F Abbvie COM 00287Y109 100,180 19,550 24.25 5,451 0.61 0.4979
2015-07-06 2015-06-30 13F Abbvie COM 00287Y109 80,630 -1,190 -1.45 5,418 13.11 0.4468
2015-04-14 2015-03-31 13F AbbVie COM 00287Y109 81,820 81,820 4,790 0.3716
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.